Home Newsletters Intestinal Cell News A Potential Treatment of Congenital Sodium Diarrhea in Patients With Activating GUCY2C...

A Potential Treatment of Congenital Sodium Diarrhea in Patients With Activating GUCY2C Mutations

0
Scientists investigated the effect of SSP2518 on guanylyl cyclase C (GCC)-mediated intracellular cyclic guanosine monophosphate levels and on GCC-mediated chloride secretion in intestinal organoids from three patients with distinct activating GCC mutations and from controls.
[Clinical and Translational Gastroenterology]

Sorry, but the selected Zotpress account can't be found.

Full Article
Exit mobile version